Recent Advances in Measuring Response to Immune Checkpoint Inhibitors

In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to treat 10 different types of cancer, in addition to solid tumors located anywhere in the body that have certain DNA damage and repair-related biomarkers. However, only a small percentage of patients respond to these treatments, and they can have significant side effects. Researchers are looking for biomarkers that can identify patients who are likely to respond to immune checkpoint inhibitors.

Read More

A Young Researcher Advocates for Strong Federal Funding

Scientific advancements are made through scientific research. From understanding the basic biology behind a disease to testing how well a drug targets a disease, the majority of this research is funded by the National Institutes of Health (NIH). So, on September 14, 2017, hundreds of people from 37 states and Washington, D.C., from over 300 institutes and organizations, gathered for the 5th Annual Rally for Medical Research with a common message

Read More

Cultivating a More Diverse Scientific Work Force

The U.S. Latino population surged 243 percent from 1980 to 2010. But in the same time span, the Latino physician work force dropped from 135 to 105 physicians per 100,000, according to a study by the Center for the Study of Latino Health and Culture at the University of California, Los Angeles.

This decline is alarming. It means that the growing Latino population does not get culturally competent care needed to improve patient health outcomes.

Read More

AACR Welcomes High School Students for National Cancer Research Month

The American Association for Cancer Research (AACR) wrapped up National Cancer Research Month by inviting a group of 50 students from Philadelphia’s George Washington Carver High School for Engineering & Science to the AACR’s Philadelphia headquarters for a morning of conversations about cancer science.

Read More

Advancing Translational Cancer Medicine in Latin America

In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer research globally and support its members residing in 107 countries in addition to the United States. One important initiative this year was the landmark conference held May 4-6, in São Paulo, Brazil—the AACR International Conference on Translational Cancer Medicine.

Read More

Public Policy and Advocacy in Cancer Research: An Associate Member Guest Post

April symbolizes a progressive time for cancer researchers around the world. From April 1-5, over 20,000 cancer scientists will gather in Washington, D.C., to attend the American Association for Cancer Research (AACR) 2017 Annual Meeting.

Read More